ワクチン技術:未来の展望
N R Rabinovich1, P McInnes, D L Klein
1Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20982-9902.
まとめ
新しいワクチン技術は,合理的な設計のための基礎科学の進歩を活用しています. 微生物の毒性や免疫反応を理解することで,感染症に対する次世代ワクチンが作れるようになる.
科学分野:
- 生物医学科学 生物医学科学とは
- 免疫学 免疫学とは
- 微生物学 微生物学とは
背景:
- ワクチンの開発は公衆衛生の礎石であり,感染症の負担を大幅に軽減しています.
- 伝統的なワクチンのアプローチは,新興および持続的な感染性病原体に対処する上で限界があります.
研究 の 目的:
- 新型ワクチン技術の現状と将来の方向性を要約する.
- 最近の科学的進歩がワクチンの設計に与える影響を強調する.
主な方法:
- 微生物の毒性因子の理解における最近の進歩のレビュー.
- 感染に対する宿主の免疫反応機構の分析.
- 新興ワクチンプラットフォームと合理的な設計の原則に関する情報の統合.
主要な成果:
- 病原体と宿主との相互作用の理解を深めることは,ワクチンの開発に不可欠です.
- 合理的な設計アプローチにより,より効果的で標的を絞ったワクチンの作成が可能になっています.
- 新しいワクチン技術は,さまざまな感染症に対する有望な戦略を提供します.
結論:
- 基礎科学の進歩は,ワクチン開発に革命を起こしています.
- 合理的な設計に基づいた次世代のワクチンは,感染症の制御に重要な可能性を秘めています.
さらに関連する動画
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
関連する概念動画
Vaccinations
Overview
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
